Other Names
- FIS
- Fell Pony Syndrome
- Foal Immunodeficiency Syndrome
- B-Lymphocyte Deficiency Syndrome
What is Equine Foal Immunodeficiency Syndrome?
Equine Foal Immunodeficiency Syndrome (FIS) is a fatal inherited disease primarily affecting Fell Ponies and Dales Ponies. It is caused by a genetic defect that prevents the production of functional B-lymphocytes — the white blood cells responsible for producing antibodies. Without B-lymphocytes, affected foals have no capacity to mount an adaptive immune response, leaving them defenceless against even minor infections that a healthy foal would easily overcome.
FIS is an autosomal recessive condition, meaning a foal must inherit two copies of the defective gene — one from each parent — to develop the disease. Carrier animals (those with one normal and one defective gene) are clinically normal but can pass the condition to their offspring. The disease is invariably fatal; affected foals typically die within the first four months of life despite intensive supportive care.
Awareness of the condition has grown significantly since the genetic mutation was identified, and DNA testing is now available to identify carrier animals before breeding decisions are made.
Causes
FIS is caused by a point mutation in the SLC5A3 gene (also described in relation to the ARHGEF6 region in some research), resulting in defective development of B-lymphocytes in the bone marrow. The condition is:
- Autosomal recessive: Both parents must carry at least one copy of the mutant allele for an affected foal to be produced
- Breed-specific: Almost exclusively reported in Fell Ponies and Dales Ponies, though cases have occasionally been suspected in other native British breeds
- Carrier prevalence: Studies have indicated that carrier frequency in the Fell Pony population may be relatively high, making genetic testing before breeding critically important
Unlike conditions such as Combined Immunodeficiency in Arabian foals, FIS involves a selective deficiency of B-cells with relatively preserved T-cell function, though T-cell function alone is insufficient to protect against the range of pathogens the foal encounters.
Symptoms and Signs
FIS-affected foals appear normal at birth and for the first several weeks of life, protected by maternal antibodies absorbed from colostrum. As these maternal antibodies wane — typically from four to eight weeks of age — signs of immunodeficiency emerge:
- Recurrent or persistent infections — respiratory, gastrointestinal, or systemic
- Progressive weight loss and failure to thrive despite adequate nursing
- Anaemia — often a prominent and early finding; FIS foals develop profound anaemia as the disease progresses
- Diarrhoea, often unresponsive to standard treatments
- Pneumonia or recurrent respiratory infections
- Skin infections or wounds that fail to heal
- General deterioration in condition and energy levels
The anaemia in FIS is a particularly distinctive feature, often severe enough to require blood transfusion, and differentiates it from simple neonatal infection or failure of passive transfer. Despite treatment, affected foals continue to decline.
Diagnosis
Definitive diagnosis requires laboratory testing:
- Complete blood count: Reveals profound anaemia and often abnormal lymphocyte populations
- Lymphocyte immunophenotyping: Flow cytometry to identify absence or severe reduction of B-lymphocytes (CD19+ or IgM+ cells) in peripheral blood — this is a definitive diagnostic marker
- Serum immunoglobulin measurement: Very low or absent IgM levels in foals old enough to have produced their own antibodies (distinguishable from maternal antibody levels)
- DNA genetic testing: Identifies homozygous affected status or carrier status in both foals and adult horses. Testing can be performed on blood or hair root samples and is the definitive method for confirming diagnosis and identifying carriers
- Bone marrow biopsy: May reveal absence of mature B-cells in the marrow, though this is rarely performed in practice given the availability of genetic testing
Genetic testing of breeding animals — both mares and stallions — before mating is the most practical and important use of available diagnostics and is strongly recommended for all Fell Pony and Dales Pony breeders.
Treatment
There is no curative treatment for FIS. The disease is invariably fatal due to the irreversible genetic nature of the immunodeficiency. Supportive care may extend survival for some weeks but cannot halt the progression:
- Antibiotics to treat active infections
- Blood transfusions to manage severe anaemia
- Nutritional support and nursing care
- Anti-parasitic treatment
Most affected foals are humanely euthanised once the diagnosis is confirmed and the prognosis understood. Prolonging life through intensive intervention is not considered ethically appropriate given the inevitable fatal outcome and the suffering involved.
Prevention
Prevention rests entirely on responsible breeding practice:
- Genetic testing: All Fell Ponies and Dales Ponies intended for breeding should be DNA tested for FIS carrier status before any mating decisions are made. Tests are available through several veterinary genetic laboratories.
- Breeding guidelines: Carrier animals should never be mated with another carrier. Carrier x non-carrier matings produce foals with a 50% chance of being carriers (but not affected) and 50% clear. Only clear x clear matings guarantee no affected foals.
- Register participation: The Fell Pony Society maintains records of testing and encourages breeders to register results, helping to reduce carrier prevalence across the breed over time
Prognosis
The prognosis for affected foals is hopeless. All foals confirmed as homozygous for the FIS mutation will die from the disease, typically within the first four months of life. No treatment can compensate for the absent B-lymphocytes. Early DNA confirmation allows breeders and owners to make humane euthanasia decisions promptly rather than subjecting foals to prolonged suffering.
When to Call the Vet
Contact your vet promptly if:
- A Fell Pony or Dales Pony foal develops recurrent infections from four weeks of age onwards
- A foal shows signs of anaemia — pale mucous membranes, weakness, rapid breathing
- A foal fails to thrive despite adequate nutrition and normal birth
- You have not had your breeding stock DNA tested and are concerned about carrier status
Frequently Asked Questions
Can carrier Fell Ponies live normal lives?
Yes, entirely. Carrier animals (one normal gene, one mutant gene) are clinically indistinguishable from non-carriers. They have normal immune function and full life expectancy. The only consideration is that they should not be mated with another carrier, and they should be identified through DNA testing so that informed breeding decisions can be made.
How common is FIS in the Fell Pony breed?
Carrier frequency studies have suggested that a significant proportion of Fell Ponies may carry the mutation. Some estimates have placed carrier prevalence at around 20–40%, though increasing uptake of genetic testing and responsible breeding practices are working to reduce this over time.
Is FIS related to SCID in Arabian foals?
Both conditions are inherited immunodeficiencies in specific horse breeds, but they are caused by different genetic mutations and affect immune function differently. SCID (Severe Combined Immunodeficiency) in Arabian foals involves a combined T and B-cell deficiency, whilst FIS primarily involves B-lymphocyte deficiency. Both are autosomal recessive and both are fatal. See also: Fell Pony breed information and Equine Viral Enteritis for infectious causes of foal illness to consider in differential diagnoses.
Where can I get my Fell Pony tested for FIS?
DNA testing for FIS is available from several veterinary genetics laboratories including the Animal Health Trust (now part of Newmarket Equine Hospital’s genetics service) and international commercial laboratories. Testing requires a blood sample or mane/tail hair roots. Contact your vet or the Fell Pony Society for current recommended testing providers.